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Abstract:  
 
We developed an improved immunohistochemical technique for distinguishing human mast cells 
of the MCT (tryptase-positive, chymase-negative) and MCTC (tryptase-positive, chymase-
positive) types utilizing a biotinylated murine anti-chymase monoclonal antibody (MAb), termed 
B7, and an alkaline phosphatase-conjugated murine anti-tryptase MAb, termed G3. The B7 MAb 
also was used to show the selective presence of chymase in mast cells. The distribution of MCT 
and MCTC cells in Carnoy's fluid-fixed tissue sections of human lung, skin, small intestine, and 
tonsils was analyzed by the new technique and the results compared to those obtained with the 
older method using a rabbit polyclonal antichymase antibody and a mouse anti-tryptase MAb in 
indirect immunoperoxidase and indirect immunoalkaline phosphatase protocols, respectively. In 
tissues known to contain predominantly mature mast cells, there were no quantitative differences 
between the two techniques, although the staining intensity achieved with the anti-chymase MAb 
was greater and without development of high background, compared to results achieved with the 
polyclonal antibody. MCT cells were the predominant type seen in the alveoli of the lung (93%) 
and in the small intestinal mucosa (81%). MCTC cells predominanted in the skin (99%) and in 
the small intestinal submucosa (77%) and, to a lesser degree, in tonsils (60%). However, in 
newborn foreskin tissue which contains predominantly immature forms of mast cells, 75% of all 
mast cells were stained uniformly and intensely with B7, whereas only 43% were stained with 
the polyclonal anti-chymase antibody. Therefore, the use of MAb provides for better 
standardization of reagents and more accurate assessment of the distribution of human MCT and 
MCTC cells in tissues than previously available methods. 
 
Keywords: Mast cell | Tryptase | Chymase | Immunohistochemistry | Heterogeneity | Human | 
Lung | Skin | Bowel | Tonsils 
 
Article: 
 
Introduction 
Two types of mature mast cells have been described in the human, on the basis of differences in 
neutral protease composition (Schwartz et al., 1987; Irani et al., 1986), ultrastructure (Craig et 
al., 1988), and dependency on T-lymphocyte function (Irani et al., 1987). The MCT cell contains 
tryptase alone; the MCTC cell contains both tryptase and chymase. Immature forms of MCT and 
MCTC cells have been described which also have distinct ultrastructural features and 
retain the protease compositional differences of their mature counterparts (Craig et al., 1989). 
The original double indirect immunohistochemical technique used to distinguish MCT and and 
MCTC cells utilized a rabbit polyclonal anti-chymase antibody (Schechter et al. , 1986) and a 
mouse anti-tryptase monoclonal antibody (MAb) (Schwartz, 1985). Using this technique with 
tissues from adult subjects and children, MCT cells were found to be the predominant mast cell 
type in small intestinal mucosa (98%) and alveoli (93%), whereas MCTC cells were the 
predominant mast cell type in skin (88%) and small intestinal submucosa (87%) (Irani et al., 
1986). However, the rabbit polyclonal antibody gives a relatively high non- specific background 
and has the disadvantages of availability and lot-to-lot standardization inherent to polyclonal 
antibodies. 
 The present article reports the characterization of newly produced mouse anti-chymase 
and anti-tryptase MAb. A modification of the previously published double immunohistochemical 
technique for detection of human MCT and MCTC cells was developed to overcome potential 
cross-linking of two antibodies from the same species. The new technique shows increased 
sensitivity for detection of immature forms of MCTC cells. 
 
Materials and Methods 
 
Materials 
 
Thirty percent H2O2 (Fisher Scientific; Fairlawn, NJ), 50% glutaraldehyde (Electron Microscopy 
Sciences; Fort Washington, PA), Alcian blue, alkaline phosphatase, biotin-amidocaproate-N-
hydroxysuccinimide ester, peroxidase-conjugated goat anti-mouse IgG, peroxidase-conjugated 
streptavidin, peroxidase-conjugated goat anti-rabbit IgG, alkaline phosphatase-conjugated goat 
anti-rabbit IgG, 3-amino-9-ethylcarbazole, fast blue RR, and naphthol AS-MX phosphoric acid 
(Sigma; St Louis, MO) were obtained as indicated. Polyclonal rabbit IgG anti-chymase was 
purified by Schechter et al. (1983). A murine myeloma IgG2b, kappa with unknown antigenic 
specificity, termed MPC-11, was obtained from American Type Culture Collection (Rockville, 
MD). Fresh surgical tissues were fixed in Carnoy’s fluid (60% ethanol, 30% chloroform, 10% 
glacial acetic acid) for 24 hr and transferred to absolute ethanol. Tissues were embedded in 
paraffin and 4 μm sections were prepared. Macroscopically normal-appearing areas of skin, lung, 
and small bowel were used. Tonsils were hypertrophied but not acutely inflamed. 
 
Preparation of Anti-tryptase Mab 
 
Human tryptase was purified to homogeneity from dispersed human lung mast cells as 
previously described (Schwartz et al., 1981) and was used to immunize BALB/c mice. Serum 
samples from immunized mice were tested for the presence of anti-tryptase antibodies by an 
indirect ELISA (Schwartz, 1985). Spleen cells from responder mice were fused with P3X63Ag8-
653 (American Type Culture Collection) murine myeloma cells. Hybridomas were grown in 
Dulbecco’s modified Eagle’s medium supplemented with 2 mmoles of L-glutamine per liter, 100 
units of penicillin-streptomycin per milliliter, and 10% (v/v) fetal calf serum. Cells were grown 
in a Lunaire model B106 1OH incubator (Lunaime Environmental; Williamsport, PA) at 37°C 
and 6% CO2. Hybridoma cells secreting antitryptase antibody were cloned and subcloned by 
limiting dilution into 96-well microtiter plates. One stable subclone, termed G3, was selected 
which secreted an anti-tryptase MAb, as determined by the indirect ELISA (Table 1). The G3 
MAb was characterized as an IgG1, kappa, antibody by an ELISA subtyping procedure 
(Boehringer-Mannheim Biochemicals; Indianapolis, IN). G3 antibody was generated in ascites 
fluid of pristane-primed BALB/c mice and was purified by chromatography on protein A-
agarose. The purified antibody selectively stained tryptase by Western blot analysis of crude 
extracts of partially purified mast cells from lung and skin and gave results identical to those 
obtained with a previously reported anti-tryptase MAb termed H4 (Schwartz, 1985). 
 Purified MAb G3 was conjugated to alkaline phosphatase by a modification of the 
technique described by Voller et al. (1976). In brief, 1000 units of alkaline phosphatase were 
added to 0.4 mg of MAb G3 in the presence of glutaraldehyde at a final concentration of 0.2% 
(v/v). The mixture was incubated for 2 hr at 4°C, then dialyzed against PBS, pH 7.4, and then 
against 0.05 M Tris buffer, pH 8.0, containing 1 mM magnesium chloride. Bovine serum 
albumin (1%)(w/v) and 0.02% sodium azide (w/v)were added to the final product. 
 
Table 1. ELISA results for anti-chymase and anti-tryptase monoclonal antibodiesa 
 
a Sera from the chymase-immunized mouse (left column) and tryptase-immunized mouse (right 
column) were tested at 1:100 dilution in PBS; hybridoma media from each cell line were tested 
undiluted.  
b Values in parentheses represent background OD obtained in the absence of chymase or tryptase 
bound to the wells. 
 
Preparation of Anti-chymase MAb 
 
Chymase, a neutral protease with chymotryptic specificity, was purified to homogeneity from 
human skin by Schechter et al. (1983) and was used to produce murine hybridomas, essentially 
as described previously for tryptase. BALB/c mice were immunized by intraperitoneal injection 
of 5 μg of chymase in complete Freund’s adjuvant on day 0, boosted with an intravenous 
injection of 5 μg of chymase in incomplete Freund’s adjuvant at 4 weeks, and boosted again at 8 
weeks, 3 days before fusion, with an intraperitoneal injection of 5 μg of chymase in PBS. Serum 
and hybridoma media were tested for the presence of anti-chymase antibody by an indirect 
ELISA. Chymase (20 ng/well) was bound to Immulon C microtitem plates (Dynatech 
Laboratories; Chantilly, VA) according to the manufacturer’s instructions. Nonspecific binding 
sites were blocked with 0.1% bovine serum albumin in PBS at pH 7.0 for 60 min at room 
temperature. Serum or hybridoma medium was added and incubated for 60 min at room 
temperature, followed by alkaline phosphatase-conjugated goat anti-mouse IgG (Boehringer-
Mannheim) for 60 min at room temperature. The wells were washed and the alkaline 
phosphatase reaction was developed with p-nitrophenyl-phosphate for 90 min at room 
temperature as described previously (Schwartz, 1985). Results of the ELISA for the B7 anti 
chymase MAb are shown in Table 1. The corresponding cloned hybridoma cell line producing 
this IgG1, kappa, anti-chymase antibody was grown in ascites of pristane-primed BALB/c mice. 
MAb B7 was purified from ascites fluid by protein A-agarose chromatography. The purified B7 
antibody failed to recognize chymase by Western blot analysis of crude extracts of dispersed 
human skin mast cells, probably because the corresponding antigenic site on chymase is tertiary 
rather than linear and is lost during the procedure. Biotinylation of purified MAb B7 was 
performed by incubating biotin-amidocaproate N-hydroxysuccinimide ester with MAb B7 (7.3 
mg/ml) in a 5:1 molar ratio, at pH 9.2 in 0.1 M sodium bicarbonate buffer for 4 hr at room 
temperature, followed by dialysis against PBS, pH 7.4, at 4°C overnight. 
 
Immunohistochemistry 
Single Staining. Cytocentrifuge preparations of dispersed human lung cells, dispersed human 
skin cells, and of purified human neutrophils, basophils, eosinophils, and mononuclear peripheral 
blood cells were obtained as described (Castells et al., 1987; Schwartz et al., 1987). Slides were 
fixed in Carnoy’s fluid for 15 mm at room temperature and subjected to indirect 
immunoperoxidase staining as previously described (Irani et al., 1986; Craig et al., 1986), unless 
stated otherwise. Endogenous peroxidase was blocked by incubation with 0.6% H2O2 in 
methanol for 30 min at room temperature, followed by washing in Tris-buffered saline with 
0.05% Tween 20, pH 7.4 (TTBS). Slides were incubated with G3 (1.5 μg/ml), B7 (1.5 μg/ml), or 
MPC-11 (1.4 μg/ml) overnight at 4°C. After washing the slides in TTBS, a 1:50 dilution of 
peroxidase-conjugated goat anti-mouse IgG was added for 1 hr at room temperature. Samples 
were washed in TTBS and a freshly prepared solution of 3-amino-9-ethyl carbazole (0.2 mg/ml 
of 0.1 M acetate buffer, pH 5.2) containing 0.01% H2O2 was applied for 8 min at room 
temperature. After a final wash in distilled water, the slides were mounted in a 90% glycerol 
solution. Positively stained cells developed a reddish-brown color. The different cell preparations 
were also stained with biotinylated B7 (2 μg/ml), followed by peroxidase-conjugated streptavidin 
(1:50) and 3-amino-9-ethyl carbazole as described above and with alkaline phosphatase-
conjugated G3 (0.7 μg/ml), followed by fast blue RR (1 mg/ml) in 0.1 M Tris, pH 8.2, containing 
naphthol AS-MX phosphate (0.2 mg/ml), which resulted in a blue color in positively stained 
cells. In addition, cytocentrifuge preparations of dispersed human lung cells were stained with 
0.1% (w/v) Alcian blue in 0.7 N HCI for 15 min at room temperature (Enerback et al., 1986) and 
mounted in 90% glycerol. Photomicroscopy of Alcian blue-positive cells was performed. The 
coverslips were then floated off and the cells were fixed in Carnoy’s solution and subjected to 
indirect immunoperoxidase with G3 or MPC-11 as described above. Photomicroscopy of the 
same cells was then repeated. 
 
Simultaneous Double Labeling with Anti-tryptase and Anti-chymase MAb. Carnoy’s-fixed 
tissue sections were de-waxed in xylene and rehydrated in graded ethanol solutions. Endogenous 
peroxidase was inhibited as above and slides were incubated with a mixture of alkaline 
phosphatase-conjugated G3 (0.7 μg/ml) and biotinylated B7 (4 μg/ml) overnight at 4°C. The 
tryptase positive cells (G3-positive) were stained blue by the addition of fast blue RR and 
naphthol AS-MX phosphate. Slides were mounted in 90% glycerol and photomicroscopy was 
performed. The coverslips were then floated off and chymase-positive cells (B7-positive) were 
stained brown by indirect immunoperoxidase utilizing peroxidase-conjugated streptavidin (1:50) 
as a secondary antibody. Photomicroscopy of the same fields was then repeated. Negative 
controls for these experiments consisted of replacing B7 by MPC-11. 
 
Simultaneous Double Labeling with Two Anti-chymase Antibodies. Tissue sections were 
processed as above and incubated with a mixture of rabbit polyclonal anti-chymase (13 μg/ml) 
and B7 mouse anti-chymase Mab (1.5 μg/ml) overnight at 4°C. Cells reacting with the 
polyclonal antibody were stained blue by addition of alkaline phosphatase-conjugated goat anti 
rabbit IgG (1:50), followed by fast blue RR and naphthol AS-MX phosphate as described above. 
After photomicroscopy was performed, B7-positive cells were stained brown by the 
immunoperoxidase technique and photomicroscopy was repeated. Negative controls for these 
experiments consisted of replacing B7 by MPC-11. 
 
Sequential Double Labeling with Anti-chymase and Anti-tryptase Antibodies. Tissue 
sections were incubated first with biotinylated B7 (4 μg/ml) or with the polyclonal anti-chymase 
antibody (13 μg/ml), overnight at 4°C, followed by indirect immunoperoxidase utilizing 
peroxidase-conjugated streptavidin and peroxidase-conjugated goat anti-rabbit IgG, respectively. 
Alkaline phosphatase-conjugated G3 (0.7 μg/ml) was then applied overnight at 4°C, followed by 
fast blue RR and naphthol AS-MX phosphate. 
 Mast cells were counted under light microscopy at x 160 magnification. Only visibly 
nucleated cells were counted. Photomicroscopy was performed with a Zeiss Ultraphot 
microscope. 
 
Results 
 
Tryptase and Chymase in Dispersed Human Mast Cells and Peripheral Blood Leukocytes 
 
In cytospin preparations of cells dispersed from mature human lung (35% mast cell purity) and 
human skin (64% mast cell purity), mast cells were stained intensely with the anti-tryptase MAb 
G3, both by an indirect immunoperoxidase technique using G3 at 1.5 μg/ml and by the direct 
technique using alkaline phosphatase conjugated G3 at 0.7 μg/ml. Mast cells dispersed from 
human skin also reacted very strongly with the anti-chymase MAb B7, at 1.5 μg/ml, and with 
biotinylated B7 at 2 μg/ml, consistent with previous results obtained with the polyclonal anti-
chymase antibody (Schwartz et al., 1987; Irani et al., 1986). No staining was seen in the negative 
control experiments using MPC-11 as a primary antibody. 
 Neither the G3 nor the B7 antibodies stained cytocentrifuge preparations of neutrophils 
(95% purity), neutrophils and eosinophils (70% and 30% purity, respectively), and lymphocytes 
and monocytes (95% and 5% purity, respectively). 
 In three cytocentrifuge preparations containing 10-30% basophils, the basophils were 
faintly stained with MAb G3 at 1.5 μg/ml in the indirect immunoperoxidase technique, but 
required very high concentrations of alkaline phosphatase-conjugated G3 (≥20 μg/ml) for 
visualization. Basophils were not stained by B7 nor by biotinylated B7 at antibody 
concentrations of up to 100 μg/ml. Therefore, at the concentrations of alkaline phosphatase-
conjugated anti-tryptase and of biotinylated anti-chymase antibodies used the following 
experiments, only mast cells are stained. Furthermore, a one-to-one correlation between Alcian 
blue-positive cells and G3-positive cells was observed in dispersed lung cells, as illustrated in 
Figures 1A and 1B, confirming the specific binding of anti-tryptase MAb G3 to mast cells. 
 
 
 
Identification of Anti-chymase MAb B7-positive Cells as Tryptase-containing Mast Cells 
 
Simultaneous double-labeling experiments utilizing alkaline phosphatase-conjugated anti-
tryptase MAb G3, together with biotinylated anti-chymase MAb B7, were conducted on sections 
of human skin and small intestine fixed in Carnoy’s fluid. In the first phase of staining, MAb G3 
stained all mast cells blue, as shown for the intestinal submucosa and mucosa (Figure 2A). In the 
second phase of the experiment, chymase-positive mast cells, or MCTC cells, known to 
predominate in the submucosa, were stained brown by MAb B7 (Figure 2B). No chymase-
positive, tryptase-negative cells were found. In addition, chymase-negative mast cells, or  MCT 
cells, remained blue after staining with antichymase MAb B7, as demonstrated for the single 
mucosal MCT cell shown in Figure 2B and for many MC-r cells in lung sections (not shown). 
When MAb B7 was replaced by MPC-11, all the mast cells remained blue. These findings have 
been reproduced in multiple sections from more than five lung, skin, and intestinal specimens.  
 
Comparison of the Polyclonal vs the Monoclonal Anti-chymase Antibodies in Staining Mast 
Cells 
 
To verify that the previously used polyclonal rabbit IgG and the monoclonal murine B7 anti-
chymase antibodies recognized exactly the same mast cell subpopulation, simultaneous double-
labeling experiments were performed utilizing polyclonal rabbit anti chymase antibody with the 
alkaline phosphatase technique, together with the murine anti-chymase MAb with the peroxidase 
technique. In a representative sample of adult skin, all mast cells reacting with the polyclonal 
antibody during the first phase of staining, visualized in blue, also reacted with MAb B7 during 
the second phase of staining and turned brown. When B7 was replaced by MPC-11, all the mast 
cells remained blue. Tissues stained with the anti-chymase MAb appeared to display less 
background staining and more intense specific staining of the mast cells than tissues stained with 
the polyclonal anti-chymase antibody. 
 To compare the sensitivities of the B7 and the rabbit polyclonal anti-chymase antibodies 
in staining mast cells, immature MCTC cells in Camnoy’s-fixed tissue sections of newborn 
foreskin were analyzed with these antibodies by the indirect immunoperoxidase technique. Mast 
cells dispersed from newborn foreskin have been shown to contain about 12% of the chymase 
and 40% of the tryptase 1evels found in mature MCTC cells (Schwartz et al., 1987). Sections 
stained with MAb B7 at 1.5 μg/ml showed uniformly intense staining of mast cells (Figure 3A), 
whereas sections stained with the polyclonal anti-chymase antibody at 26 μg/ml showed a wide 
range of staining intensity which on average was much weaker than with B7, and which showed 
a higher level of background and lower numbers of positively stained mast cells (Figure 3B). 
 
Distribution of MCT and MCTC Cells in Normal Human Tissues 
 
Sequential double-labeling experiments were performed on tissue sections fixed with Carnoy’s 
fluid as described in Methods. As previously reported with the polyclonal anti-chymase antibody 
(Irani et al., 1986), deposition of the brown peroxidase-dependent reaction product in chymase-
positive MCTC cells stained with MAb B7 blocks the subsequent staining of tryptase present in 
these cells by alkaline phosphatase-conjugated anti-tryptase MAb G3. As a result, only chymase-
negative MCT cells bind G3 and are stained blue with the alkaline phosphatase substrate, whereas 
MCTC cells remain brown, allowing a clear distinction between the two types of mast cells. The 
increased intensity of the brown stain with MAb B7 over the polyclonal anti-chymase antibody 
better suppresses the staining of MCTC cells by anti-tryptase antibody. This difference is crucial, 
as MCTC cells that are not visibly stained by the polyclonal antibody will react with the anti-
tryptase antibody and be erroneously recognized as MCT cells. 
 The percent distribution of MCT and MCTC cells in normal adult human skin, lung, small 
intestine, and tonsils was similar whether the sections were stained with MAb B7 or the 
polyclonal anti-chymase antibodies. Table 2 shows the results obtained with B7. As previously 
reported, MCTC cells were the predominant type found in the skin, where they were 
concentrated in the superficial dermis around blood vessels and appendigeal structures. In six of 
seven specimens, MCTC cells were the exclusive type. In the seventh specimen, which consisted 
of breast skin, several MCT cells were present around glandular structures. In the alveolar wall of 
the lungs, mast cells were almost exclusively of the MCT type, with MCTC cells being seen 
around venules and arterioles. In six of eight small intestinal specimens studied, the mucosa 
contained more than 85% MCT cells (Figure 4A). However, in two specimens there was an 
approximately equal distribution of MCT and MCTC cells in the mucosa (Figure 4B). Each 
specimen was obtained from jejunum removed at surgery for a gastric bypass procedure and 
appeared to be normal by routine histology when reviewed by the pathologist. The small 
intestinal submucosa contained a majority of MCTC cells in each specimen studied. In tonsil 
tissue mast cells were found in the connective tissue, where an approximately equal distribution 
of MCT and MCTC cells was demonstrated. Only MCT cells were seen in the lymphoid follicles, 
although few in number. The epithelium was mostly devoid of mast cells, except in one 
specimen where many MCT  mast cells were seen in the epithelium just above the basement 
membrane. 
 Five different specimens of newborn foreskin were subjected to the sequential double-
labeling technique utilizing MAb B7 and polyclonal anti-chymase antibody on adjacent tissue 
sections, respectively. The number of mast cells analyzed ranged from 200-800 per specimen. 
The results are shown in Table 3. In specimens incubated with B7, 25% of the mast cells stained 
as MCT cells, while in those incubated with the polyclonal anti-chymase antibody 57% of the 
mast cells stained as MCT cells. Since the polyclonal anti-chymase antibody failed to detect all 
chymase-positive cells in the newborn foreskin, as demonstrated above, the latter figure reflects 
falsely elevated numbers of MCT cells. 
 
Table 2. Distribution of MCT and MCTC cells in human tissues from adult subjects
a 
 
a Tissue sections were stained by the sequential double-labeling technique with 
biotin-B7 and alkaline phosphatasc-G3. 
 
Table 3. Distribution of MCT and MCTC cells in newborn foreskin tissue
a 
 
aTissue sections were stained by the sequential double-labeling technique using either biotin-B7 
or rabbit polyclonal anti-chymase antibodies and alkaline phosphatase-G3. 
 
Discussion 
 
New monoclonal anti-tryptase (G3) and anti-chymase (B7) anti- bodies were produced and 
utilized for detection of human MCT and MCTC cells. At the concentrations used for staining, 
both MAb recognized only mast cells in tissue sections of human lung, skin, and bowel and in 
cytocentrifuge preparations of peripheral blood cells, dispersed human lung cells, and dispersed 
human skin cells. MAb G3 does not appear to recognize shared epitopes in other cell types, 
unlike the previously described anti-tryptase MAb called G5 (Craig et al., 1986; Schwartz, 
1985), which stains neutrophils weakly by reacting with a crossreactive epitope on a protein 
distinct from tryptase. G3 binds to tryptase more effectively than the anti-tryptase MAb called 
H4 (Schwartz, 1985; Schwartz et al., 1985), as evidenced by ELISA and immunohistochemical 
staining intensity. Furthermore, MAb G3, like G5 but unlike H4, stains mast cells in thin sections 
by immunogold electron microscopy (unpublished data). Using these new MAb in the present 
study, all chymase containing mast cells were shown to contain tryptase, as previously reported 
(Craig et al., 1987; Irani et al., 1986). In addition, no chymase was detected by 
immunohistochemistry in peripheral blood neutrophils, eosinophils, lymphocytes, monocytes, 
and basophils, indicating its selective presence in MCTC cells. 
 Because both MAb were from the same murine species, a new indirect 
immunohistochemical staining technique was developed to differentiate between MCT and MCTC 
cells. The procedure utilized biotinylated anti-chymase antibody and alkaline phosphatase-
conjugated anti-tryptase antibody, thereby avoiding the use of secondary anti-mouse antibody 
that would crossreact with both primary antibodies. A similar double-labeling technique has been 
described by Sako et al. (1986), utilizing immunogold-silver staining in conjunction with the 
avidin-biotin-peroxidase complex method for simultaneous detection of T-cells and B-cells with 
two mouse MAb. 
 Percentages of MCT and MCTC cells in mature human tissues using the original and new 
techniques were similar. The new technique offers the advantages associated with the use of 
monoclonal antibodies, i.e., unlimited supply, increased staining intensity, and decreased 
nonspecific background staining. 
 The distribution of MCT and MCTC cells in skin, lung, and small intestinal submucosa 
was similar to what has been reported previously, with MCTC cells predominating in the dermis 
and small intestinal submucosa and MCT cells predominating in the alveoli. However, in the 
present series of small intestinal specimens, more variation was seen in the mucosal distribution 
of mast cell types, with six of eight specimens showing the expected predominance of MCT cells 
and the other two specimens showing equal proportions of MCT and MCTC cells. As all 
specimens were obtained and processed in a similar fashion and no underlying pathology was 
found in any, the results probably reflect normal variation. These findings stress further the 
importance of analyzing the distribution of MCT and MCTC cells in any individual preparation of 
mast cells, to unambiguously define the cell types that are present. 
 The distribution of mast cell types in tonsil tissue was analyzed and approximately equal 
numbers of MCT and MCTC cells were found in the connective tissue. Mast cells seen in 
lymphoid follicles and epithelium were exclusively of the MCT type, perhaps reflecting T-
lymphocyte factors in the local environment which may facilitate the appearance or development 
of MCT cells. Such a phenomenon is believed to be responsible for the appearance of MCT cells 
in the inflamed areas of rheumatoid synovium (Irani et al., 1987). These observations, in turn, are 
consistent with the apparent dependence of MCT cells on functional T-lymphocytes, as assessed 
by the selective deficiency of MCT cells in the small intestinal mucosa of subjects with acquired 
immunodeficiency syndrome as well as subjects with inherited combined immunodeficiency dis- 
eases (Irani et al., 1987). 
 A major improvement offered by the new technique is the ability to detect immature as 
well as mature forms of MCTC cells in tissue sections. As shown by Craig et al. (1988), 
essentially all mast cells in the foreskin of newborn infants were immature and at various stages 
of development, whereas only a small proportion of mast cells in adult lung, foreskin, and small 
intestine (5%-15%) appeared immature. Mast cells dispersed from newborn foreskin were shown 
to contain decreased amounts of tryptase (two- to threefold lower) and chymase (eight- to tenfold 
lower) compared to mast cells from adult foreskin (Schwartz et al., 1987). Mast cells in 
cytocentrifuge preparations of dispersed newborn foreskin were stained much less intensely with 
polyclonal anti-chymase antibody than mast cells dispersed from adult foreskin (Schwartz et al., 
1987). Similarly, the polyclonal anti-chymase antibody results in weak on negative staining of 
mast cells in tissue sections of newborn foreskin, even at the high concentration of 26 μg/ml. The 
polyclonal antibody probably stains the more developed forms of immature mast cells which 
contain higher levels of chymase, whereas the least developed forms are stained very weakly or 
not at all. In contrast, the staining intensity obtained in tissue sections with the new anti-chymase 
MAb B7 appears to be as great for mast cells from newborn foreskin as for mast cells from adult 
foreskin. 
 Immature MCTC cells that are not detected with the polyclonal anti-chymase antibody are 
stained by the anti-tryptase MAb G3 subsequently added to the tissue sections and are 
erroneously detected as MCT cells. Given that only the least mature forms of MCTC cells would 
be mislabeled by the older immunohistochemical technique, previous reports of the distribution 
of mast cell types in various tissues could have underestimated the percentage of the MCTC type 
by 5-15%, based on the percentage of immature mast cells in adult tissues (Craig et al., 1989). 
This may explain the higher percentage of MCTC cells in adult human skin reported here (99%) 
as compared with the previous report of 88% MCTC cells in human skin (Irani et al., 1986). On 
the other hand, this study demonstrated that 25% of the mast cells in tissue sections of new- born 
foreskin are of the MCI type. We had previously shown, in cytocentrifuge preparations of cells 
dispersed from newborn foreskin and stained by the older immunohistochemical technique, that 
1% of the mast cells were of the MCI type (Schwartz et al., 1987). The different results obtained 
previously may reflect either a preferential dispersion and/or purification of MCTC cells from 
new- born foreskin tissue or a failure of the weaker anti-tryptase MAb H4 used in that study to 
stain immature MCT cells 
 The involvement of MCT and MCTC cells in various disease states may have pathogenic, 
prognostic, or therapeutic implications. The new immunohistochemical technique described in 
this report utilizes reagents that are better standardized, accurate, and more readily available for 
determination of the distribution of MCT and MCTC cells in various tissues in health and disease. 
 
Literature Cited 
 
Castells MC, Irani AA, Schwartz LB (1987): Evaluation of human periph- eral blood leukocytes 
for mast cell tryptase. J Immunol 138:2184  
 
Craig SS, Dc Blois G, Schwartz LB (1986): Mast cells in human keloid, small 
intestine, and lung by an immunoperoxidase technique using a murine monoclonal antibody 
against tryptase. Am J Pathol 124:427  
 
Craig SS, Schechter NM, Schwartz LB (1989): Ultrastructural analysis of maturing human T and 
it mast cells in situ. Lab Invest 60:147  
 
Craig SS, Schechter NM, Schwartz LB (1988): Ultrastructural analysis of human T and it mast 
cells identified by immunoelectron microscopy. Lab Invest 58:682 
 
Irani AA, Craig 55, DeBlois G, Elson CO, Schechter NM, Schwartz LB (1987): 
Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa 
of patients with defective T lymphocyte function. J Immunol 138:4381 
 
Irani AA, Golzar N, DeBlois G, Gruber B, Schwartz LB (1987): Distribution ofmast cell subsets 
in rheumatoid arthritis and osteoarthritis synovia. Arthritis Rheum 30:66 
 
Irani AA, Schechter NM, Craig 55, Dc Blois G, Schwartz LB (1986): Two types of human mast 
cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA  83:4464 
 
Sako H, Nakane Y, Okino K, Nishihara K, Kodama M, Kawata M, Yamada H (1986): 
Simultaneous detection of B cells and T cells by a double im- muonhistochemical technique 
using immunogold-silver staining and the avidin-biotin-peroxidase complex method. 
Histochemistry 86:1 
 
Schechter NM, Choi JK, Slavin DA, Pleresienski DT, Sayama 5, Dong G, Lavker RM, Proud D, 
Lazarus G (1986): Identification of a chymotrypsinlike proteinase in human mast cells. J 
Immunol 137:962 
 
Schechter NM, Fraki JE, Geesin JC, Lazarus GS (1983): Human skin chymotryptic proteinase, 
isolation and relation to cathepsin G and rat mast cell proteinase 1. J Biol Chem 258:2973 
 
Schwartz LB (1985): Monoclonal antibodies against human mast cell tryptase demonstrate 
shared antigenic sites on subunits of tryptase and selective localization of the enzyme to mast 
cells. J Immunol 134:526 
 
Schwartz LB, FoleyJV, Austen KF, Soter NA, Shepard R, Murphy GF(1985): Localization of 
tryptase to human cutaneous mast cells and keratinocytes by immunofluorescence and 
immunoperoxidase cytochemistry with mono- clonal antitryptase antibody. J Allergy Clin 
Immunol 76:182 
 
Schwartz LB. Irani AA, Roller K, Castells MC, Schechter NM (1987): Quantitation of histamine, 
tryptase and chymase in dispersed human T and it mast cells. J Immunol 138:2611 
 
Schwartz LB. Lewis RA, Austen KF (1981): Tryptase from human pulmonary mast cells: 
purification and characterization. J Biol Chem 256:11939 
 
Voller A, Bidwell DE, Bartlett A (1976): Enzyme immunoassay in diagnostic medicine. Theory 
and practice. Bull WHO 53:55 
 
 
 
 
 
